Arcutis Biotherapeutics, Inc. (ARQT) insider trading

Insider

Date

Role

Action

Shares

Price

Amount

Masaru Matsuda

4 Nov 2026

EVP, Chief Legal Officer

Sold after exercise

40,000

$34.32

$1.37M

Howard G. Welgus

15 Oct 2026

Director

Sold after exercise

4,728

$26.93

$127.33K

Howard G. Welgus

15 Sep 2026

Director

Sold after exercise

4,730

$24.18

$114.37K

Terrie Curran

27 Aug 2026

Director

Sold after exercise

27,052

$25.03

$677.10K

Terrie Curran

27 Aug 2026

Director

Sold after exercise

11,148

$25.03

$279.03K

Terrie Curran

20 Aug 2026

Director

Sold after exercise

1,072

$26.04

$27.91K

Howard G. Welgus

17 Aug 2026

Director

Sold after exercise

4,730

$26.18

$123.83K

Patrick Burnett

12 Aug 2026

See Remarks

Sold after exercise

6,700

$26.08

$174.77K

Patrick Burnett

11 Aug 2026

See Remarks

Sold after exercise

8,300

$26.52

$220.13K

Howard G. Welgus

15 Jul 2026

Director

Sold after exercise

4,730

$26.91

$127.28K

Howard G. Welgus

15 Jun 2026

Director

Sold after exercise

4,096

$24.41

$99.98K

Keith R Leonard

2 Mar 2026

Director

Sold after exercise

39,272

$25.39

$997.19K

Patrick Burnett

15 Dec 2025

See Remarks

Sold after exercise

11,500

$28.94

$332.85K

Sue-Jean Lin

24 Nov 2025

Director

Sold after exercise

25,272

$30.78

$777.96K

Halley E Gilbert

20 Nov 2025

Director

Sold after exercise

16,532

$27.55

$455.44K

Neha Krishnamohan

13 Nov 2025

Director

Sold after exercise

1,232

$23.37

$28.79K

Neha Krishnamohan

13 Nov 2025

Director

Sold after exercise

39,272

$23.19

$910.70K

Patrick Burnett

6 Nov 2025

See Remarks

Sold after exercise

17,250

$24.18

$417.14K

Arcutis Biotherapeutics, Inc.

What the insiders did Net selling

Individual transactions

What was left out